In this regard, the persistent STAT3 activation has been observed in the residual survivor lung cancer cells both in vitro and in vivo under targeted TKIs, suggesting that early STAT3 phosphorylation may represent an important transcriptional programming event prior to the resurgence of resistant tumor survivors [16]. The gene discussed is STAT3; the disease is neoplasm.